Literature DB >> 21881832

Exploring the role of soluble factors associated with immune regulatory properties of mesenchymal stem cells.

Ênio José Bassi1, Danilo Candido de Almeida, Pedro Manoel Mendes Moraes-Vieira, Niels Olsen Saraiva Câmara.   

Abstract

Mesenchymal stem cells (MSCs) are characterized as multipotent stromal cells with the capacity for both self-renewal and differentiation into mesodermal cell lineages. MSCs also have a fibroblast-like phenotype and can be isolated from several tissues. In recent years, researchers have found that MSCs secrete several soluble factors that exert immunosuppressive effects by modulating both innate (macrophages, dendritic and NK cells) and adaptive (B cells and CD4+ and CD8+ T cells) immune responses. This review summarizes the principal trophic factors that are related to immune regulation and secreted by MSCs under both autoimmune and inflammatory conditions. The understanding of mechanisms that regulate immunity in MSCs field is important for their future use as a novel cellular-based immunotherapy with clinical applications in several diseases.

Mesh:

Substances:

Year:  2012        PMID: 21881832     DOI: 10.1007/s12015-011-9311-1

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  19 in total

1.  Adipose-tissue-derived and Wharton's jelly-derived mesenchymal stromal cells suppress lymphocyte responses by secreting leukemia inhibitory factor.

Authors:  Mehdi Najar; Gordana Raicevic; Hicham Id Boufker; Hussein Fayyad-Kazan; Cécile De Bruyn; Nathalie Meuleman; Dominique Bron; Michel Toungouz; Laurence Lagneaux
Journal:  Tissue Eng Part A       Date:  2010-08-30       Impact factor: 3.845

2.  Comparison of gene expression of umbilical cord vein and bone marrow-derived mesenchymal stem cells.

Authors:  Rodrigo A Panepucci; Jorge L C Siufi; Wilson A Silva; Rodrigo Proto-Siquiera; Luciano Neder; Maristela Orellana; Vanderson Rocha; Dimas T Covas; Marco A Zago
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

3.  In vitro and in vivo differentiation of human umbilical cord derived stem cells into endothelial cells.

Authors:  Kai Hong Wu; Bin Zhou; Shi Hong Lu; Bin Feng; Shao Guang Yang; Wei Ting Du; Dong Sheng Gu; Zhong Chao Han; Ying Long Liu
Journal:  J Cell Biochem       Date:  2007-02-15       Impact factor: 4.429

4.  Adipose tissue-derived mesenchymal stem cells are more potent suppressors of dendritic cells differentiation compared to bone marrow-derived mesenchymal stem cells.

Authors:  Ekaterina Ivanova-Todorova; Ivan Bochev; Milena Mourdjeva; Rumen Dimitrov; Dimitar Bukarev; Stanimir Kyurkchiev; Petar Tivchev; Iskra Altunkova; Dobroslav Stanimirov Kyurkchiev
Journal:  Immunol Lett       Date:  2009-07-30       Impact factor: 3.685

Review 5.  Mechanisms involved in the therapeutic properties of mesenchymal stem cells.

Authors:  Lindolfo da Silva Meirelles; Aparecida Maria Fontes; Dimas Tadeu Covas; Arnold I Caplan
Journal:  Cytokine Growth Factor Rev       Date:  2009-11-18       Impact factor: 7.638

Review 6.  Leukemia inhibitory factor and human embryo implantation.

Authors:  Lusine Aghajanova
Journal:  Ann N Y Acad Sci       Date:  2004-12       Impact factor: 5.691

Review 7.  Chemokines as regulators of T cell differentiation.

Authors:  S A Luther; J G Cyster
Journal:  Nat Immunol       Date:  2001-02       Impact factor: 25.606

8.  Tissue resident stem cells produce CCL5 under the influence of cancer cells and thereby promote breast cancer cell invasion.

Authors:  Severin Pinilla; Eckhard Alt; F J Abdul Khalek; Constantin Jotzu; Fabian Muehlberg; Christoph Beckmann; Yao-Hua Song
Journal:  Cancer Lett       Date:  2009-05-07       Impact factor: 8.679

Review 9.  The inflammatory chemokines CCL2 and CCL5 in breast cancer.

Authors:  Gali Soria; Adit Ben-Baruch
Journal:  Cancer Lett       Date:  2008-04-24       Impact factor: 8.679

10.  Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells.

Authors:  Zohair Selmani; Abderrahim Naji; Ines Zidi; Benoit Favier; Emilie Gaiffe; Laurent Obert; Christophe Borg; Philippe Saas; Pierre Tiberghien; Nathalie Rouas-Freiss; Edgardo D Carosella; Frederic Deschaseaux
Journal:  Stem Cells       Date:  2007-10-11       Impact factor: 6.277

View more
  34 in total

1.  Emerging roles for multipotent, bone marrow-derived stromal cells in host defense.

Authors:  Jeffery J Auletta; Robert J Deans; Amelia M Bartholomew
Journal:  Blood       Date:  2012-01-06       Impact factor: 22.113

Review 2.  The potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis.

Authors:  Jeffery J Auletta; Amelia M Bartholomew; Richard T Maziarz; Robert J Deans; Robert H Miller; Hillard M Lazarus; Jeffrey A Cohen
Journal:  Immunotherapy       Date:  2012-05       Impact factor: 4.196

3.  Mouse Bone Marrow Sca-1+ CD44+ Mesenchymal Stem Cells Kill Avirulent Mycobacteria but Not Mycobacterium tuberculosis through Modulation of Cathelicidin Expression via the p38 Mitogen-Activated Protein Kinase-Dependent Pathway.

Authors:  Sumanta Kumar Naik; Avinash Padhi; Geetanjali Ganguli; Srabasti Sengupta; Sanghamitra Pati; Dasarathi Das; Avinash Sonawane
Journal:  Infect Immun       Date:  2017-09-20       Impact factor: 3.441

Review 4.  Mesenchymal stem cells: a friend or foe in immune-mediated diseases.

Authors:  Marina Gazdic; Vladislav Volarevic; Nebojsa Arsenijevic; Miodrag Stojkovic
Journal:  Stem Cell Rev Rep       Date:  2015-04       Impact factor: 5.739

Review 5.  Mesenchymal stem cells: Potential role in corneal wound repair and transplantation.

Authors:  Fei Li; Shao-Zhen Zhao
Journal:  World J Stem Cells       Date:  2014-07-26       Impact factor: 5.326

Review 6.  In search of mechanisms associated with mesenchymal stem cell-based therapies for acute kidney injury.

Authors:  Danilo C de Almeida; Cassiano Donizetti-Oliveira; Priscilla Barbosa-Costa; Clarice St Origassa; Niels Os Câmara
Journal:  Clin Biochem Rev       Date:  2013-11

7.  In vivo immunological properties research on mesenchymal stem cells based engineering cartilage by a dialyzer pocket model.

Authors:  Tun Yuan; Hongrong Luo; Likun Guo; Hongsong Fan; Jie Liang; Yujiang Fan; Xingdong Zhang
Journal:  J Mater Sci Mater Med       Date:  2017-08-22       Impact factor: 3.896

8.  Rheological characterization of dynamic remodeling of the pericellular region by human mesenchymal stem cell-secreted enzymes in well-defined synthetic hydrogel scaffolds.

Authors:  Maryam Daviran; Sarah M Longwill; Jonah F Casella; Kelly M Schultz
Journal:  Soft Matter       Date:  2018-04-25       Impact factor: 3.679

9.  CD39-mediated effect of human bone marrow-derived mesenchymal stem cells on the human Th17 cell function.

Authors:  Jong Joo Lee; Hyun Jeong Jeong; Mee Kum Kim; Won Ryang Wee; Won Woo Lee; Seung U Kim; Changmin Sung; Yung Hun Yang
Journal:  Purinergic Signal       Date:  2013-09-17       Impact factor: 3.765

10.  Multipotent stromal cells skew monocytes towards an anti-inflammatory interleukin-10-producing phenotype by production of interleukin-6.

Authors:  Sara M Melief; Sacha B Geutskens; Willem E Fibbe; Helene Roelofs
Journal:  Haematologica       Date:  2013-01-24       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.